# FDA recall D-0532-2023

> **Pfizer Inc.** · Class III · drug recall initiated 2023-03-08.

## Product

MEKTOVI (binimetinib) tablets, 15 mg, 180-count bottle, Rx only, Distributed by: Array BioPharma Inc., a wholly owned subsidiary of Pfizer Inc., Boulder, CO 80301.  NDC:  70255-010-02

## Reason for recall

Labeling: Incorrect or Missing Lot and/or Exp Date:  The carton and bottle labels state an expiry date of March 2026; the correct expiration date is February 2025.

## Distribution

Nationwide in the USA

## Key facts

- **Recall number:** D-0532-2023
- **Recalling firm:** Pfizer Inc.
- **Classification:** Class III
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2023-03-08
- **Report date:** 2023-04-19

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** New York, NY, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0532-2023

## Citation

> AI Analytics. FDA recall D-0532-2023. Retrieved 2026-07-26 from https://api.ai-analytics.org/recall/D-0532-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*